WUXI XDC THE BIOCONJUGATION LEADER Trademark

Trademark Overview


On Saturday, September 18, 2021, a trademark application was filed for WUXI XDC THE BIOCONJUGATION LEADER with the United States Patent and Trademark Office. The USPTO has given the WUXI XDC THE BIOCONJUGATION LEADER trademark a serial number of 97034358. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 10, 2024. This trademark is owned by WuXi XDC Cayman Inc.. The WUXI XDC THE BIOCONJUGATION LEADER trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; chemico-pharmaceutical preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; drugs for medical purposes, namely, anticancer preparations; biological preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; medicines for human purposes for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; medicines for human purposes in the nature of bioconjugate preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; pharmaceutical preparations, substances and compositions...
wuxi xdc the bioconjugation leader

General Information


Serial Number97034358
Word MarkWUXI XDC THE BIOCONJUGATION LEADER
Filing DateSaturday, September 18, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 13, 2022

Trademark Statements


Description of MarkThe mark consists of the stylized wordings "WUXI" over "XDC", partially inside an incomplete oval outline that intersects with another incomplete oval outline. Below these appears the wording "THE BIOCONJUGATION LEADER" in stylized font.
Goods and ServicesPharmaceutical preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; chemico-pharmaceutical preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; drugs for medical purposes, namely, anticancer preparations; biological preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; medicines for human purposes for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; medicines for human purposes in the nature of bioconjugate preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; pharmaceutical preparations, substances and compositions, namely, antibody-drug conjugates in the nature of medical diagnostic reagents; pharmaceutical preparations, namely, drug conjugates consisting primarily of pharmaceutical preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease
NOT AVAILABLE"WUXI" OR "BIOCONJUGATION"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 22, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameWuXi XDC Cayman Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWuxi, Jiangsu Province 214028
CN

Party NameWuXi XDC Cayman Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWuxi, Jiangsu Province 214028
CN

Trademark Events


Event DateEvent Description
Wednesday, September 22, 2021NEW APPLICATION ENTERED
Friday, October 22, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 23, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, June 22, 2022ASSIGNED TO EXAMINER
Tuesday, June 28, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, June 28, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, June 28, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, June 28, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, August 9, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 24, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 13, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 13, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 8, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, May 5, 2023SOU TEAS EXTENSION RECEIVED
Friday, May 5, 2023TEAS REQUEST TO DIVIDE RECEIVED
Friday, May 5, 2023DIVISIONAL REQUEST RECEIVED
Friday, May 5, 2023SOU EXTENSION 1 FILED
Tuesday, May 30, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 1, 2023DIVISIONAL PROCESSING COMPLETE
Thursday, June 1, 2023SOU EXTENSION 1 GRANTED
Thursday, October 26, 2023SOU TEAS EXTENSION RECEIVED
Thursday, October 26, 2023SOU EXTENSION 2 FILED
Thursday, October 26, 2023SOU EXTENSION 2 GRANTED
Saturday, October 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 10, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, June 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 2, 2023CORRECTED NOA E-MAILED